MX2014012799A - Tabletas recubiertas y la produccion de las mismas. - Google Patents
Tabletas recubiertas y la produccion de las mismas.Info
- Publication number
- MX2014012799A MX2014012799A MX2014012799A MX2014012799A MX2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A
- Authority
- MX
- Mexico
- Prior art keywords
- coating
- production
- tablets
- formulations
- hardness
- Prior art date
Links
- 239000011248 coating agent Substances 0.000 title abstract 2
- 238000000576 coating method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención proporciona una formulación farmacéutica que se desintegra rápidamente en la forma de una tableta recubierta que tiene una resistencia mecánica o dureza incrementada. La invención se refiere adicionalmente a un proceso para la producción de la tableta recubierta y el uso de esas formulaciones.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12002988 | 2012-04-27 | ||
| EP12006370 | 2012-09-11 | ||
| PCT/EP2013/000971 WO2013159861A1 (de) | 2012-04-27 | 2013-04-02 | Tabletten mit überzug und deren herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014012799A true MX2014012799A (es) | 2015-01-22 |
| MX369549B MX369549B (es) | 2019-11-12 |
Family
ID=48045412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014012799A MX369549B (es) | 2012-04-27 | 2013-04-02 | Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20150104512A1 (es) |
| EP (1) | EP2844234B1 (es) |
| JP (2) | JP6363993B2 (es) |
| KR (1) | KR102092002B1 (es) |
| CN (1) | CN104244931A (es) |
| BR (1) | BR112014026439B1 (es) |
| CA (1) | CA2871703C (es) |
| CL (1) | CL2014002896A1 (es) |
| ES (1) | ES2784134T3 (es) |
| IL (1) | IL234998B (es) |
| MX (1) | MX369549B (es) |
| TW (2) | TW201811316A (es) |
| WO (1) | WO2013159861A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| MY191729A (en) * | 2015-10-16 | 2022-07-13 | Novex Science Pte Ltd | Stable composition of vitamin c and zinc tablet |
| JP6738477B2 (ja) * | 2016-03-16 | 2020-08-12 | ゴールデン オメガ ノルウェー アーエス | ω−3脂肪酸誘導体を含む粉末及び錠剤、ならびにその製造方法 |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| JP2018184375A (ja) * | 2017-04-27 | 2018-11-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法 |
| US11826473B2 (en) | 2018-01-11 | 2023-11-28 | Sawai Pharmaceutical Co., Ltd. | Orally disintegrating tablet coated with film |
| JP7750663B2 (ja) * | 2021-03-19 | 2025-10-07 | エスエス製薬株式会社 | 被覆固形医薬製剤 |
| CN118340736B (zh) * | 2024-04-23 | 2024-10-18 | 海南恒诚三叶制药有限公司 | 头孢泊肟酯片及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100346832C (zh) * | 2002-02-07 | 2007-11-07 | 法玛西雅公司 | 经粘膜递送的药物剂型 |
| JP2008507587A (ja) * | 2004-07-26 | 2008-03-13 | テバ ファーマシューティカル インダストリーズ リミティド | 腸溶性被覆されたコアー錠剤を有する投与形 |
| BRPI0513598A (pt) * | 2004-07-26 | 2008-05-13 | Teva Pharma | formas de dosagem em comprimidos revestidos de liberação entérica |
| JP5535616B2 (ja) * | 2006-03-31 | 2014-07-02 | ルビコン リサーチ プライベート リミテッド | 口腔内崩壊錠剤のための直接圧縮性複合材 |
| EP2066307B1 (en) | 2006-09-15 | 2012-07-04 | Capsugel Belgium NV | Rapidly disintegrating dosage form |
| KR101442862B1 (ko) * | 2006-12-07 | 2014-09-22 | 다이이찌 산쿄 가부시키가이샤 | 만니톨 또는 유당을 함유하는 고형 제제 |
| EA201000545A1 (ru) * | 2007-10-12 | 2010-10-29 | Астразенека Аб | Композиция зиботентана, содержащая маннит и/или микрокристаллическую целлюлозу |
| WO2009135646A2 (en) * | 2008-05-05 | 2009-11-12 | Farmaprojects, Sa | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale |
| EP2299982B1 (de) * | 2008-06-20 | 2018-04-04 | Merck Patent GmbH | Direkt verpressbare und schnell zerfallende tablettenmatirx |
| HRP20240365T1 (hr) * | 2009-02-13 | 2024-06-07 | Boehringer Ingelheim International Gmbh | Farmaceutski pripravak koji sadrži derivate glukopiranozil difenilmetana, njegov farmaceutski oblik za doziranje, postupak za njihovu proizvodnju i njihove uporabe za poboljšanu regulaciju glikemije kod pacijenta |
| TWI455733B (zh) * | 2009-03-30 | 2014-10-11 | Toray Industries | 口腔內崩壞性被覆錠劑 |
| EP2506835B1 (en) | 2009-11-30 | 2019-06-12 | Adare Pharmaceuticals, Inc. | Compressible-coated pharmaceutical compositions and tablets and methods of manufacture |
| TR201907882T4 (tr) * | 2012-02-22 | 2019-06-21 | Fujifilm Toyama Chemical Co Ltd | 1-(3-(2-(1-Benzotiofen-5-il)etoksi)propil)azetidin-3-olü veya onun tuzunu içeren katı farmasötik bileşim |
-
2013
- 2013-04-02 BR BR112014026439-2A patent/BR112014026439B1/pt active IP Right Grant
- 2013-04-02 KR KR1020147033314A patent/KR102092002B1/ko active Active
- 2013-04-02 EP EP13713755.0A patent/EP2844234B1/de active Active
- 2013-04-02 JP JP2015507401A patent/JP6363993B2/ja active Active
- 2013-04-02 CN CN201380021358.6A patent/CN104244931A/zh active Pending
- 2013-04-02 US US14/396,166 patent/US20150104512A1/en not_active Abandoned
- 2013-04-02 CA CA2871703A patent/CA2871703C/en active Active
- 2013-04-02 WO PCT/EP2013/000971 patent/WO2013159861A1/de not_active Ceased
- 2013-04-02 MX MX2014012799A patent/MX369549B/es active IP Right Grant
- 2013-04-02 ES ES13713755T patent/ES2784134T3/es active Active
- 2013-04-24 TW TW106131271A patent/TW201811316A/zh unknown
- 2013-04-24 TW TW102114599A patent/TWI697341B/zh active
-
2014
- 2014-10-05 IL IL234998A patent/IL234998B/en active IP Right Grant
- 2014-10-24 CL CL2014002896A patent/CL2014002896A1/es unknown
-
2017
- 2017-08-03 JP JP2017150868A patent/JP2017193585A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6363993B2 (ja) | 2018-07-25 |
| IL234998B (en) | 2019-07-31 |
| BR112014026439B1 (pt) | 2022-05-31 |
| JP2015514786A (ja) | 2015-05-21 |
| TWI697341B (zh) | 2020-07-01 |
| TW201410268A (zh) | 2014-03-16 |
| CA2871703C (en) | 2021-03-30 |
| JP2017193585A (ja) | 2017-10-26 |
| EP2844234B1 (de) | 2020-01-08 |
| CA2871703A1 (en) | 2013-10-31 |
| TW201811316A (zh) | 2018-04-01 |
| EP2844234A1 (de) | 2015-03-11 |
| KR102092002B1 (ko) | 2020-03-23 |
| BR112014026439A2 (pt) | 2017-06-27 |
| KR20150003891A (ko) | 2015-01-09 |
| CL2014002896A1 (es) | 2014-12-19 |
| IL234998A0 (en) | 2014-12-31 |
| US20150104512A1 (en) | 2015-04-16 |
| ES2784134T3 (es) | 2020-09-22 |
| WO2013159861A1 (de) | 2013-10-31 |
| MX369549B (es) | 2019-11-12 |
| CN104244931A (zh) | 2014-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX369549B (es) | Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento. | |
| IL269054A (en) | A pharmaceutical preparation containing tesimaltone for use in the treatment of 24-NON | |
| PH12019501970A1 (en) | Pharmaceutical compositions for combination therapy | |
| CA141113S (en) | Dispenser for pharmaceutical powder formulations | |
| IL222268A (en) | Preserved pyrollo-pyridines, containing pharmaceutical preparations, combined preparations containing them and their use in the preparation of medicines | |
| IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
| MX2013008850A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
| AU346046S (en) | Shower faceplate | |
| GB201106750D0 (en) | Novel compounds | |
| AU338203S (en) | Pill case | |
| MX2014008774A (es) | Sistemas de perfume. | |
| CA143485S (en) | Display box | |
| PH12019501301A1 (en) | Pharmaceutical compositions for combination therapy | |
| AU345217S (en) | Fire detector | |
| GB2497453B (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
| GB201222455D0 (en) | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease | |
| MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
| MX2013001793A (es) | Producto para la esfera gastrica superior. | |
| IN2015DN02358A (es) | ||
| WO2011107866A3 (en) | Silyl-derivatives of polysaccharides | |
| MX2012002631A (es) | Capsulas con aroma. | |
| MX2015013755A (es) | Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis. | |
| WO2014027979A3 (en) | Tablet formulations comprising tadalafil and dapoxetine | |
| UA105944C2 (uk) | Комбінація теоброміну з деконгестантом і її застосування для лікування кашлю | |
| MX2014006201A (es) | Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |